Print Back to story

Cypress Bioscience, Inc. to Present at Cowen and Company 29th Annual Health Care Conference

marketwire
Press Release Source: Cypress Bioscience, Inc. On Wednesday March 18, 2009, 6:30 am EDT

SAN DIEGO, CA--(MARKET WIRE)--Mar 18, 2009 -- Cypress Bioscience, Inc. (NasdaqGM:CYPB - News) today announced that Sabrina Martucci Johnson, its Chief Operating Officer and Chief Financial Officer, will present at the Cowen and Company 29th Annual Health Care Conference on March 19, 2009.

The Cowen conference is being held at the Boston Marriott Copley Place, Boston, MA. Ms. Johnson is scheduled to present on Thursday, March 19th at 11:05 a.m. Eastern Time. The audio broadcast of this presentation can be accessed at http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=CYPB&item_id=2111184.

A replay of the presentation will be available at the same web address as well as on Cypress' website, http://www.cypressbio.com/events.php.

About Cypress Bioscience

Cypress Bioscience, Inc. provides therapeutics and personalized medicine services, facilitating improved and individualized patient care. Cypress addresses the evolving needs of specialist physicians and their patients by identifying unmet medical needs in the areas of pain, rheumatology, and physical medicine and rehabilitation, including challenging disorders such as fibromyalgia and rheumatoid arthritis. This approach to improving patient care creates a unique partnership with physicians. Current products include Savella(TM) (milnacipran HCI) and the Avise PG(SM) and Avise MCV(SM) therapeutic monitoring, diagnostic and prognostic tests for rheumatoid arthritis.

For more information about Cypress, please visit the Company's website at www.cypressbio.com.

Contact:

     For additional information please contact
      
     Mary Gieson
     Investor Relations
     (858) 452-2323
     Email Contact
      

Copyright © 2009 CCNMatthews. CCNMatthews All rights reserved. All news releases provided by CCNMatthews are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.